These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 38348717
1. Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1. Yuan Z, Xiong B, Liu L, Lu Y, Liu Y, Wang G, Qian Y, Diao B, Tu M. J Biochem Mol Toxicol; 2024 Feb; 38(2):e23656. PubMed ID: 38348717 [Abstract] [Full Text] [Related]
2. Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma. Xu Y, Yao Y, Liu Y, Wang Z, Hu Z, Su Z, Li C, Wang H, Jiang X, Kang P, Sun D, Zhong X, Cui Y. Aging (Albany NY); 2019 Apr 04; 11(7):1907-1917. PubMed ID: 30946694 [Abstract] [Full Text] [Related]
3. Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256. Chen S, Chen Z, Li Z, Li S, Wen Z, Cao L, Chen Y, Xue P, Li H, Zhang D. Cell Death Dis; 2022 Jan 28; 13(1):94. PubMed ID: 35091535 [Abstract] [Full Text] [Related]
4. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells. Xu Y, Yao Y, Zhong X, Leng K, Qin W, Qu L, Cui Y, Jiang X. Biochem Biophys Res Commun; 2018 Feb 05; 496(2):455-461. PubMed ID: 29337065 [Abstract] [Full Text] [Related]
5. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation. Xu Y, Gao P, Wang Z, Su Z, Liao G, Han Y, Cui Y, Yao Y, Zhong X. J Cell Mol Med; 2021 Apr 05; 25(7):3226-3238. PubMed ID: 33675150 [Abstract] [Full Text] [Related]
6. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. Yang R, Chen Y, Tang C, Li H, Wang B, Yan Q, Hu J, Zou S. BMC Cancer; 2014 Dec 05; 14():917. PubMed ID: 25479763 [Abstract] [Full Text] [Related]
7. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis. Yao X, Mao Y, Wu D, Zhu Y, Lu J, Huang Y, Guo Y, Wang Z, Zhu S, Li X, Lu Y. Cancer Lett; 2021 Aug 01; 512():38-50. PubMed ID: 33971282 [Abstract] [Full Text] [Related]
8. A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers. Xu Y, Leng K, Yao Y, Kang P, Liao G, Han Y, Shi G, Ji D, Huang P, Zheng W, Li Z, Li J, Huang L, Yu L, Zhou Y, Jiang X, Wang H, Li C, Su Z, Tai S, Zhong X, Wang Z, Cui Y. Hepatology; 2021 Apr 01; 73(4):1419-1435. PubMed ID: 32750152 [Abstract] [Full Text] [Related]
9. Circ_0000591 served as endogenous RNA for miR-326 to promote progression of cholangiocarcinoma via the TLR4/MyD88/IL6 axis. Xiao F, Xu F, Zhang H, Shuai X. Biochem Biophys Res Commun; 2022 Apr 16; 600():101-108. PubMed ID: 35248826 [Abstract] [Full Text] [Related]
10. Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation. Shu L, Li X, Liu Z, Li K, Shi A, Tang Y, Zhao L, Huang L, Zhang Z, Zhang D, Huang S, Lian S, Sheng G, Yan Z, Zhang Z, Xu Y. Hepatology; 2024 Feb 01; 79(2):307-322. PubMed ID: 37140231 [Abstract] [Full Text] [Related]
11. Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42. Liu S, Guan C, Sha X, Gao X, Zou X, Yang C, Zhang X, Zhong X, Jiang X. Cell Signal; 2024 Jun 01; 118():111141. PubMed ID: 38492624 [Abstract] [Full Text] [Related]
12. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes. Kitdumrongthum S, Metheetrairut C, Charoensawan V, Ounjai P, Janpipatkul K, Panvongsa W, Weerachayaphorn J, Piyachaturawat P, Chairoungdua A. Life Sci; 2018 Oct 01; 210():65-75. PubMed ID: 30165035 [Abstract] [Full Text] [Related]
13. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma. Liu B, Hu Y, Qin L, Peng XB, Huang YX. Dig Liver Dis; 2019 Mar 01; 51(3):397-411. PubMed ID: 30314946 [Abstract] [Full Text] [Related]
14. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma. Li D, Tang Z, Gao Z, Shen P, Liu Z, Dang X. Mol Cell Biol; 2020 Jul 14; 40(15):. PubMed ID: 32423991 [Abstract] [Full Text] [Related]
15. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma. Wu X, Xia M, Chen D, Wu F, Lv Z, Zhan Q, Jiao Y, Wang W, Chen G, An F. Tumour Biol; 2016 Nov 14; 37(11):15019-15029. PubMed ID: 27658773 [Abstract] [Full Text] [Related]
16. CircSETD3 (hsa_circ_0000567) inhibits proliferation and induces apoptosis in cholangiocarcinoma cells via downregulation of microRNA-421 expression. Xiong W, Zhang A, Xiao X, Liu W. Bioengineered; 2022 Apr 14; 13(4):10191-10201. PubMed ID: 35435120 [Abstract] [Full Text] [Related]
17. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122. Zhu H, Mi Y, Jiang X, Zhou X, Li R, Wei Z, Jiang H, Lu J, Sun X. J Cancer Res Clin Oncol; 2016 May 14; 142(5):969-80. PubMed ID: 26825606 [Abstract] [Full Text] [Related]
18. Exosomal circRNAs: new players in the field of cholangiocarcinoma. Louis C, Desoteux M, Coulouarn C. Clin Sci (Lond); 2019 Nov 15; 133(21):2239-2244. PubMed ID: 31654054 [Abstract] [Full Text] [Related]
19. Tumor Cell-Derived Extracellular Vesicles Promote the Growth, Metastasis and Chemoresistance in Cholangiocarcinoma by Delivering microRNA-210 to Downregulate RECK. Fu Y, Liu Y, Liu K, Tan L. Mol Biotechnol; 2023 Jul 15; 65(7):1151-1164. PubMed ID: 36454533 [Abstract] [Full Text] [Related]
20. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma. Zhang L, Jiang G, Lu J, Wang L. Clin Transl Oncol; 2024 Feb 15; 26(2):414-423. PubMed ID: 37400667 [Abstract] [Full Text] [Related] Page: [Next] [New Search]